Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.

Herbert Y. Meltzer*, Michael Davidson, Alexander H. Glassman, W. Victor R Vieweg

*Corresponding author for this work

Research output: Contribution to journalReview article

45 Citations (Scopus)

Abstract

The atypical antipsychotic drugs are a major advance in the treatment of psychosis in spite of concerns about metabolic and cardiovascular side effects that affect morbidity and mortality. Concerns about weight gain, hypoglycemia, diabetes, and increases in lipids as well as sudden death due to torsades de pointes and other cardiovascular events can temper enthusiasm about the atypical antipsychotics. The challenge for the clinician is to weigh the benefits and risks for each drug for each patient and develop a treatment plan with the individual patient in mind. This article discusses both risks and benefits of antipsychotic treatment and presents a treatment algorithm to aid the clinician in choosing medications for the psychotic patient.

Original languageEnglish (US)
Pages (from-to)25-29
Number of pages5
JournalThe Journal of clinical psychiatry
Volume63 Suppl 9
StatePublished - Jan 1 2002

Fingerprint

Antipsychotic Agents
Torsades de Pointes
Therapeutics
Sudden Death
Hypoglycemia
Psychotic Disorders
Weight Gain
Morbidity
Lipids
Mortality
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Meltzer, Herbert Y. ; Davidson, Michael ; Glassman, Alexander H. ; Vieweg, W. Victor R. / Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. In: The Journal of clinical psychiatry. 2002 ; Vol. 63 Suppl 9. pp. 25-29.
@article{ea5912a71c964401afc6f21274959116,
title = "Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.",
abstract = "The atypical antipsychotic drugs are a major advance in the treatment of psychosis in spite of concerns about metabolic and cardiovascular side effects that affect morbidity and mortality. Concerns about weight gain, hypoglycemia, diabetes, and increases in lipids as well as sudden death due to torsades de pointes and other cardiovascular events can temper enthusiasm about the atypical antipsychotics. The challenge for the clinician is to weigh the benefits and risks for each drug for each patient and develop a treatment plan with the individual patient in mind. This article discusses both risks and benefits of antipsychotic treatment and presents a treatment algorithm to aid the clinician in choosing medications for the psychotic patient.",
author = "Meltzer, {Herbert Y.} and Michael Davidson and Glassman, {Alexander H.} and Vieweg, {W. Victor R}",
year = "2002",
month = "1",
day = "1",
language = "English (US)",
volume = "63 Suppl 9",
pages = "25--29",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",

}

Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. / Meltzer, Herbert Y.; Davidson, Michael; Glassman, Alexander H.; Vieweg, W. Victor R.

In: The Journal of clinical psychiatry, Vol. 63 Suppl 9, 01.01.2002, p. 25-29.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.

AU - Meltzer, Herbert Y.

AU - Davidson, Michael

AU - Glassman, Alexander H.

AU - Vieweg, W. Victor R

PY - 2002/1/1

Y1 - 2002/1/1

N2 - The atypical antipsychotic drugs are a major advance in the treatment of psychosis in spite of concerns about metabolic and cardiovascular side effects that affect morbidity and mortality. Concerns about weight gain, hypoglycemia, diabetes, and increases in lipids as well as sudden death due to torsades de pointes and other cardiovascular events can temper enthusiasm about the atypical antipsychotics. The challenge for the clinician is to weigh the benefits and risks for each drug for each patient and develop a treatment plan with the individual patient in mind. This article discusses both risks and benefits of antipsychotic treatment and presents a treatment algorithm to aid the clinician in choosing medications for the psychotic patient.

AB - The atypical antipsychotic drugs are a major advance in the treatment of psychosis in spite of concerns about metabolic and cardiovascular side effects that affect morbidity and mortality. Concerns about weight gain, hypoglycemia, diabetes, and increases in lipids as well as sudden death due to torsades de pointes and other cardiovascular events can temper enthusiasm about the atypical antipsychotics. The challenge for the clinician is to weigh the benefits and risks for each drug for each patient and develop a treatment plan with the individual patient in mind. This article discusses both risks and benefits of antipsychotic treatment and presents a treatment algorithm to aid the clinician in choosing medications for the psychotic patient.

UR - http://www.scopus.com/inward/record.url?scp=0347064997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347064997&partnerID=8YFLogxK

M3 - Review article

C2 - 12088173

AN - SCOPUS:0347064997

VL - 63 Suppl 9

SP - 25

EP - 29

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

ER -